Healing Lodge First Face Training Evaluation Study

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to evaluate a culturally grounded training program, xaʔtus (meaning First Face) for Mental Health. This program will train community members in how to recognize and respond to youth and adults experiencing mental health crises and ways to serve as a bridge between these individuals and the help they need. All Healing Lodge staff are being asked to complete First Face training. To evaluate First Face, the investigators will ask all trainees to complete surveys before and after training, and again 3 months later. These surveys will measure knowledge about mental health and addiction, as well as the ability and confidence to respond appropriately to mental health crises. The study will help the investigators understand whether the First Face training program influences mental health and attitudes, as well as responses to mental health crisis situations.

Clinical Trial Description

With funding from the National Institutes for Health, the investigators created First Face for Mental Health. First Face is a culturally-appropriate community-based mental health training that prepares trainees to provide assistance to someone having a mental health crisis. The more community members within Tribal nations who are trained in a culturally sensitive program to provide support to youth in recovery and members struggling with mental health problems or crises, the better positioned that community is to create a supportive recovery environment for its youth. The investigators are in the process of launching First Face trainings and evaluations among several Tribal communities. Additionally, they will be training staff from the Healing Lodge of the Seven Nations (HL) in the First Face program. This particular application concerns the evaluation of First Face training among HL staff. The investigators will measure primary and secondary outcomes at pre-training, post-training, and 3-month follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06290180
Study type	Interventional
Source	Cambridge Health Alliance
Contact	Melinda Bowman, EdD
Phone	(509) 795-8342
Email	melindab@healinglodge.org
Status	Not yet recruiting
Phase	N/A
Start date	April 4, 2024
Completion date	March 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03576768` - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt	N/A
Completed	`NCT04110626` - Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
Completed	`NCT03007940` - Using NIATx Strategies to Implement Integrated Services in Routine Care	N/A
Not yet recruiting	`NCT04030858` - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery	N/A
Completed	`NCT03347643` - The Effectiveness of tDCS on Internet Game Addiction	Phase 2
Active, not recruiting	`NCT02836080` - Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)	N/A
Completed	`NCT03221985` - ESM Pilot: Mobile Phones and Psychology	N/A
Completed	`NCT02556060` - Lamotrigine for Ketamine Dependence Trial	Phase 2/Phase 3
Completed	`NCT02812810` - Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence	N/A
Completed	`NCT01531153` - Cognitive Enhancement as a Target for Cocaine Pharmacotherapy	N/A
Recruiting	`NCT05976646` - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion	Phase 1/Phase 2
Completed	`NCT04409106` - The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
Recruiting	`NCT05595759` - Violence Against Women in Patients With Alcohol Substance Addiction Training	N/A
Completed	`NCT04099173` - A Brief Mindfulness-Based Intervention for Suicidal Ideation	N/A
Recruiting	`NCT04959643` - Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
Completed	`NCT04133688` - Mobile App in Addiction	N/A
Recruiting	`NCT04063267` - Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder	Phase 2
Completed	`NCT05114577` - Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery	N/A
Terminated	`NCT02671240` - Prognosis of Behavioral Addiction in Parkinson's Disease
Not yet recruiting	`NCT03813095` - Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.